Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

EVONIK INDUSTRIES AG

(EVK)
  Report
Real-time Estimate Quote. Real-time Estimate Tradegate - 08/05 11:45:30 am
28.915 EUR   -2.81%
11:39aGLOBAL MARKETS LIVE : Robinhood, Bayer, MetLife, Uber, WPP...
06:28aEVONIK INDUSTRIES : hikes 2021 guidance but quarterly beat lags peers
RE
06:01aEVONIK : Barclays reiterates its Buy rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Evonik Industries : Virtual Innovation Conference, Zürich (Berenberg)

06/08/2021 | 03:57am EDT

Delivering innovative solutions by connecting technology and business to drive sustainable growth

08 June 2021

Andreas Fischer (CIO)

As ONE Evonik, innovation is deeply rooted in group strategy Leading beyond chemistry to drive sustainable growth and profitability

Ongoing portfolio transformation

  • Target: Specialty portfolio with 100% growth businesses

Ambitious financial targets

  • EBITDA margin: 18-20%
  • Cash conversion ratio: >40%
  • ROCE: 11%

LEADING

BEYOND

CHEMISTRY

Innovation & Sustainability as growth drivers

  • €1 bn additional sales from innovation growth fields by 2025
  • Growing portfolio share of "Next Generation Solutions"

Performance-driven corporate culture

  • Further drive
    gender and cultural diversity
  • Deliver on efficiency programs in Administration & Operations

2 | 08 June 2021 | Andreas Fischer | Research & Development

The ONE Evonik strategy is reflected in our new RD&I setup

ONE Evonik

Executive Board

Divisions

Specialty

Nutrition &

Smart

Performance

Technology &

Additives

Care

Materials

Materials

Infrastructure

Regions

Research, Development &

Innovation

ONE RD&I

Research, Development &

Innovation

R&D Nutrition & Care

R&D Resource Efficiency

R&D Performance Materials

Creavis

Evonik Venture Capital

Steering

ONE Portfolio

  • Leverage Synergies ("Speed of Light" - mRNA)
  • Integrate sustainability in portfolio management by PARC analysis

3 | 08 June 2021 | Andreas Fischer | Research & Development

Our strategy

with an aligned set of goals contributing to Evonik's success

We deliver innovative solutions by connecting technology & business to drive sustainable growth

Sustainability

Growth & Profitability

Platform Technologies

We develop sustainable solutions

We create opportunities

We make the best use

as a key factor in decision-making and key

to achieve our financial target of €1 bn

of our resources with shared technology

success factor for future growth

additional sales by 2025 with products of

platforms and focus on our most promising

our six innovation growth fields

projects

  • Deliver R&D on new product and processes
  • Create & grow businesses beyond core
  • Recruit and develop new talents

Our activities…

  • Steer portfolio and optimize resource allocation
  • Manage partnerships with key customers, startups and universities
  • Build reputation as a seal of quality for customers, investors, employees and talents

4 | 08 June 2021 | Andreas Fischer | Research & Development

Bundling our biotechnology competencies into one platform Consistent focus on future topics

Biotechnology Platform

Program & Project Management

Systems Biotechnology

Process Biotechnology

In silico

Target

Microbial

~200 employees

Factory

Process Design

> 100 products

Systems

Systems

Systems

Success Stories

Gut Health Solutions

Veramaris

Biosurfactants

Lab Operations

5 | 08 June 2021 | Andreas Fischer | Research & Development

This is an excerpt of the original content. To continue reading it, access the original document here.

Disclaimer

Evonik Industries AG published this content on 08 June 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 08 June 2021 07:56:07 UTC.


© Publicnow 2021
All news about EVONIK INDUSTRIES AG
11:39aGLOBAL MARKETS LIVE : Robinhood, Bayer, MetLife, Uber, WPP...
06:28aEVONIK INDUSTRIES : hikes 2021 guidance but quarterly beat lags peers
RE
06:01aEVONIK : Barclays reiterates its Buy rating
MD
05:44aEVONIK : Bernstein reaffirms its Buy rating
MD
05:23aEVONIK : Warburg Research sticks Neutral
MD
04:44aEVONIK : Baader Bank reiterates its Sell rating
MD
03:38aEVONIK : JP Morgan reiterates its Buy rating
MD
12:56aEVONIK INDUSTRIES : grows strongly in the first half of the year and raises outl..
PU
08/02EVONIK INDUSTRIES : acquires German biotech company JeNaCell to expand biomateri..
PU
08/02Evonik Industries AG acquired JeNaCell GmbH.
CI
More news
Financials
Sales 2021 13 380 M 15 838 M 15 838 M
Net income 2021 765 M 906 M 906 M
Net Debt 2021 2 621 M 3 103 M 3 103 M
P/E ratio 2021 18,3x
Yield 2021 3,90%
Capitalization 13 864 M 16 408 M 16 410 M
EV / Sales 2021 1,23x
EV / Sales 2022 1,18x
Nbr of Employees 32 745
Free-Float 41,1%
Chart EVONIK INDUSTRIES AG
Duration : Period :
Evonik Industries AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVONIK INDUSTRIES AG
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 20
Last Close Price 29,75 €
Average target price 31,35 €
Spread / Average Target 5,37%
EPS Revisions
Managers and Directors
Christian Kullmann Chairman-Executive Board
Ute Wolf Chief Financial Officer
Bernd Tönjes Chairman-Supervisory Board
Andreas Fischer Chief Innovation Officer
Siegfried Luther Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
EVONIK INDUSTRIES AG11.51%16 408
BASF SE2.86%72 367
SHIN-ETSU CHEMICAL CO., LTD.0.17%68 537
DUPONT DE NEMOURS, INC.4.43%38 960
ROYAL DSM N.V.23.40%35 121
BRENNTAG SE36.34%15 792